AVMA news
CDC eases entry requirements for dogs vaccinated in United States
The Centers for Disease Control and Prevention removed permit requirements for dogs returning to the U.S., effective Dec. 1, provided those dogs were…
AVMA news
New listings in AVMA Animal Health Studies Database - Jan. 1, 2022
See new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
When adopting a dog, staying within US a safer option, expert says
An expert with the Centers for Disease Control and Prevention says it’s important for veterinarians to help clients understand the risks for…
JAVMA news
Drug-resistant hookworms spreading in dogs, parasitologists warn
Multidrug-resistant hookworms are spreading among dogs in the U.S., and parasitologists recommend that veterinarians follow up on anthelmintic…
JAVMA news
Helping diabetic pets live happily ever after
Diagnosing diabetes mellitus in cats and dogs is pretty straightforward, but treatment and monitoring can be complex—especially with more options…
JAVMA news
US suspends dog importation from 100-plus countries
The Centers for Disease Control and Prevention suspended, for at last one year, importation of dogs from 113 countries in an effort to prevent…
JAVMA news
Longtime canine epilepsy treatment gains conditional approval
Food and Drug Administration officials granted conditional approval of a chewable potassium bromide tablet, KBroVet-CA1, for the control of seizures…
JAVMA news
FDA gives conditional approval to canine lymphoma drug
The agency granted the conditional approval through the Minor Use/Minor Species regulatory pathway, which lets companies sell treatments for uncommon…
JAVMA news
Back to Basics
Veterinarians today are able to provide better and more advanced medical care for pets than ever before, but the cost of that care makes it out of…
JAVMA news
To titer or to revaccinate
It remains confusing and even controversial whether antibody titers are a good measure of immunity when making decisions about
JAVMA news
Canine cancer drug loses approval
The Food and Drug Administration canceled a temporary approval for a drug used to treat mast cell tumors in dogs.